KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jean-Baptiste Bachet Pierre Laurent-Puig Valérie Boige |
| Publication date | April 1, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |